Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
Catalog No. | Product Name | Size | List Price (US$) | Quantity |
---|
Price/availability/specifications subject to change without notice. Unless otherwise indicated, our catalog and customized products are for research use only and not intended for human or animal diagnostic or therapeutic use.
Phone: 1-617-401-8149
Fax: 1-617-606-5019
Email: message@sydlabs.com
Or leave a message with a formal purchase
order (PO) Or credit card.
Background Information:
VX-702 is an orally bioavailable p38 MAP kinase inhibitor developed to treat inflammatory diseases.
Reference:
1. C. Ding, VX-702, a MAP kinase inhibitor for rheumatoid arthritis and acute coronary syndrome, Current Opinion in Investigational Drugs, 2006 7:1020-1025.
APIM050260: VX-702
CAS No.: 479543-46-9.
Molecular Formula: C19H12F4N4O2.
Molecular Weight: 404.32.
Purity: > 99% (HPLC).
QC: LC/MS, 1HNMR, HPLC.
Solubility: Soluble in DMSO.
Storage: Store at 0°C (short term), -20°C (long term), desiccated.
Copyright © 2009-2022 sydlabs.com. All rights reserved.
Use of this website means that you have read, understood, and accepted the Syd Labs Privacy Policy and Terms & Conditions.